Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « MeshFr.i » - entrée « Association de médicaments »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Association amoxicilline-clavulanate de potassium < Association de médicaments < Association de pipéracilline et de tazobactam  Facettes :

List of bibliographic references indexed by Association de médicaments

Number of relevant bibliographic references: 185.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000230 (2021) Faryal Khamis [Oman] ; Hanan Al Naabi [Oman] ; Adil Al Lawati [Oman] ; Zaiyana Ambusaidi [Oman] ; Mariam Al Sharji [Oman] ; Umkulthum Al Barwani [Oman] ; Nenad Pandak [Oman] ; Zakariya Al Balushi [Oman] ; Maher Al Bahrani [Oman] ; Issa Al Salmi [Oman] ; Ibrahim Al-Zakwani [Oman]Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia.
000235 (2021) Bashar Fteiha [Israël] ; Hani Karameh [Israël] ; Ramzi Kurd [Israël] ; Batsheva Ziff-Werman [Israël] ; Itamar Feldman [Israël] ; Alon Bnaya [Israël] ; Sharon Einav [Israël] ; Amir Orlev [Israël] ; Eli Ben-Chetrit [Israël]QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.
000266 (2021) Jean-Michel Scherrmann [France]Possible Role of ABCB1 in Lysosomal Accumulation of Azithromycin in COVID-19 Therapy.
000290 (2021) Nursel Çal K Ba Aran [Turquie] ; O Uz Abdullah Uyaro Lu [Turquie] ; Gülçin Telli Dizman [Turquie] ; Lale Öz K [Turquie] ; Taha Koray Ahin [Turquie] ; Zahit Ta [Turquie] ; Ahmet Ça Kan Nkaya [Turquie] ; Sevilay Karahan [Turquie] ; Ehnaz Alp [Turquie] ; Alpaslan Alp [Turquie] ; Gökhan Metan [Turquie] ; P Nar Zarakol [Turquie] ; Gülay Sain Güven [Turquie] ; Erife Gül Öz [Turquie] ; Arzu Topeli [Turquie] ; Ömrüm Uzun [Turquie] ; Murat Akova [Turquie] ; Serhat Ünal [Turquie]Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU
000296 (2021) Victoria Birlutiu ; Rares Mircea Birlutiu ; Liana Chicea [Roumanie]Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience.
000307 (2021) Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde]Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
000317 (2021) Masashi Ohe [Japon] ; Ken Furuya [Japon] ; Houman Goudarzi [Japon]Multidrug treatment for COVID-19.
000318 (2021) Nathaniel J. Rhodes [États-Unis] ; Atheer Dairem [États-Unis] ; William J. Moore [États-Unis] ; Anooj Shah [États-Unis] ; Michael J. Postelnick [États-Unis] ; Melissa E. Badowski [États-Unis] ; Sarah M. Michienzi [États-Unis] ; Jaime L. Borkowski [États-Unis] ; Radhika S. Polisetty [États-Unis] ; Karen Fong ; Emily S. Spivak ; James R. Beardsley [États-Unis] ; Cory M. Hale [États-Unis] ; Andrea M. Pallotta [États-Unis] ; Pavithra Srinivas [États-Unis] ; Lucas T. Schulz [États-Unis]Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States.
000340 (2021) Bahad R Ta L Dere [Turquie] ; Liljana Mehmetaj [Turquie] ; Ay E Bü Ra Özcan [Turquie] ; Bedia Gülen [Turquie] ; Nazan Ta L Dere [Turquie]Melkersson-Rosenthal Syndrome Induced by COVID-19.
000342 (2021) T S Brandon Ng ; Kori Leblanc ; Darwin F. Yeung ; Teresa S M. Tsang [Canada]Medication use during COVID-19: Review of recent evidence.
000364 (2021) Pravash Budhathoki [Népal] ; Dhan Bahadur Shrestha [Népal] ; Sitaram Khadka [Népal] ; Era Rawal [Népal]Is Hydroxychloroquine with Azithromycin a Good Combination in COVID-19 Compared to Hydroxychloroquine Alone from Cardiac Perspective? A Systematic Review and Meta-Analysis.
000385 (2021) Raina Zhang ; Eleftherios MylonakisIn inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon β-1a differed from standard care for in-hospital mortality.
000399 (2021) Brahim Halil Özdemir [Turquie] ; Bülent Özlek [Turquie] ; Mehmet Burak Özen [Turquie] ; Ramazan Gündüz [Turquie] ; Nurullah Çetin [Turquie] ; Ali R Za Bilge [Turquie]Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID-19.
000401 (2021) Thomas F. O'Connell [États-Unis] ; Christopher J. Bradley [États-Unis] ; Amr E. Abbas [États-Unis] ; Brian D. Williamson [États-Unis] ; Akash Rusia [États-Unis] ; Adam M. Tawney [États-Unis] ; Rick Gaines [États-Unis] ; Jason Schott [États-Unis] ; Alex Dmitrienko [États-Unis] ; David E. Haines [États-Unis]Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19.
000411 (2021) Alexandre B. Cavalcanti [Brésil] ; Otávio Berwanger [Brésil] ; Fernando G. Zampieri [Brésil]Hydroxychloroquine with or without Azithromycin in Covid-19. Reply.
000421 (2021) Elif Tanriverd [Turquie] ; Mustafa Çörtük [Turquie] ; Binnaz Zeynep Yildirim [Turquie] ; Efsun Gonca U Ur Chousein [Turquie] ; Demet Turan [Turquie] ; Halit Çinarka [Turquie] ; Mehmet Akif Özgül [Turquie] ; Erdo An Çetinkaya [Turquie]Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data
000463 (2021) Mical Paul [Israël]Has the door closed on hydroxychloroquine for SARS-COV-2?
000485 (2021) Michael G. Kim [États-Unis] ; Alan A. Stein [États-Unis] ; Philip Overby [États-Unis] ; George Kleinman [États-Unis] ; Rolla Nuoman [États-Unis] ; Edwin Gulko [États-Unis] ; Fawaz Al-Mufti [États-Unis] ; Jared M. Pisapia [États-Unis] ; Carrie R. Muh [États-Unis]Fatal Cerebral Edema in a Child With COVID-19.
000504 (2021) Nurullah Okumu [Turquie] ; Ne E Demirtürk [Turquie] ; R Za Aytaç Çetinkaya [Turquie] ; Rahmet Güner [Turquie] ; Smail Ya Ar Avc [Turquie] ; Semiha Orhan [Turquie] ; Petek Konya [Turquie] ; Bengü Aylan [Turquie] ; Ay Egül Karalezli [Turquie] ; Levent Yamanel [Turquie] ; Bircan Kayaaslan [Turquie] ; Gülden Y Lmaz [Turquie] ; Ümit Sava Ç [Turquie] ; Fatma Eser [Turquie] ; Gürhan Ta K N [Turquie]Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
000508 (2021) Payam Tabarsi [Iran] ; Saghar Barati [Iran] ; Hamidreza Jamaati [Iran] ; Sara Haseli [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Zahra Abtahian [Iran] ; Alireza Dastan [États-Unis] ; Sahar Yousefian [Iran] ; Raha Eskandari [Iran] ; Ali Saffaei [Iran] ; Fatemeh Monjazebi [Iran] ; Abdolbaset Vahedi [Iran] ; Farzaneh Dastan [Iran]Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
000520 (2021) Falasca Katia [Italie] ; Di Penta Myriam [Italie] ; Claudio Ucciferri [Italie] ; Antonio Auricchio [Italie] ; Marta Di Nicola [Italie] ; Michele Marchioni [Italie] ; Celletti Eleonora [Italie] ; Sabatini Emanuela [Italie] ; Francesco Cipollone [Italie] ; Jacopo Vecchiet [Italie]Efficacy of canakinumab in mild or severe COVID-19 pneumonia.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Association de médicaments" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Association de médicaments" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Association de médicaments
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021